Clinical trial
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or…
NCT00123760 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00123760 |
|---|---|
| Title | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer |
| Official title | A Phase I/II, Phase III and Extended Phase III Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Brain Neoplasms, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Lymphoma |
| Intervention type | Procedure |
| Interventions | Positron Emission Tomography (PET) scan |
| Enrollment | 10,838 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 26, 2005 |
| Last update posted | Feb 25, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: